These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24099976)

  • 41. Impact of implanted recalled sprint Fidelis lead on patient mortality.
    Morrison TB; Friedman PA; Kallinen LM; Hodge DO; Crusan D; Kumar K; Hayes DL; Rea RF; Hauser RG
    J Am Coll Cardiol; 2011 Jul; 58(3):278-83. PubMed ID: 21737019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of early failure of Biotronik Linox Smart implantable cardioverter-defibrillator leads: A comparative study of three defibrillator leads.
    Pérez Díez D; Rubín JM; Calvo Cuervo D; García Iglesias D; Morís De La Tassa C
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1165-1170. PubMed ID: 29894002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study.
    Cantillon DJ; Ha K; Styperek R; Jumrussirikul P; Mirro M; Wong W; Wilkoff BL
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):855-62. PubMed ID: 23617316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Internal insulation breaches in an implantable cardioverter-defibrillator lead with redundant conductors.
    Hauser RG; Sengupta J; Schloss EJ; Stanberry LI; Wananu MK; Abdelhadi R
    Heart Rhythm; 2019 Aug; 16(8):1215-1222. PubMed ID: 30772531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.
    Ellis CR; Rottman JN
    Heart Rhythm; 2009 May; 6(5):619-24. PubMed ID: 19389648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High prevalence of insulation failure with externalized cables in St. Jude Medical Riata family ICD leads: fluoroscopic grading scale and correlation to extracted leads.
    Parvathaneni SV; Ellis CR; Rottman JN
    Heart Rhythm; 2012 Aug; 9(8):1218-24. PubMed ID: 22449742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implantable cardioverter-defibrillator lead failure in children and young adults: a matter of lead diameter or lead design?
    Janson CM; Patel AR; Bonney WJ; Smoots K; Shah MJ
    J Am Coll Cardiol; 2014 Jan; 63(2):133-40. PubMed ID: 24140671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead.
    Hauser RG; Kallinen LM; Almquist AK; Gornick CC; Katsiyiannis WT
    Heart Rhythm; 2007 Jul; 4(7):892-6. PubMed ID: 17599673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of high-voltage conductor fractures in Sprint Fidelis leads.
    Koneru JN; Gunderson BD; Sachanandani H; Wohl BN; Kendall KT; Swerdlow CD; Ellenbogen KA
    Heart Rhythm; 2013 Jun; 10(6):813-8. PubMed ID: 23454808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-Term Performance of the Riata/ST Implantable Cardioverter-Defibrillator Lead.
    Ströker E; de Asmundis C; Vanduynhoven P; De Vadder K; De Vusser P; Mullens W; Chierchia GB; Brugada P; Czapla J; La Meir M; Wellens F; Van Herendael H; Rivero-Ayerza M
    Am J Cardiol; 2016 Mar; 117(5):807-12. PubMed ID: 26762730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early fatigue fractures in the IS-1 connector leg of a small-diameter ICD lead: value of returned product analysis for improving device safety.
    Hauser RG; Kallinen Retel LM
    Heart Rhythm; 2013 Oct; 10(10):1462-8. PubMed ID: 23871705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disproportionality analysis for signal detection of implantable cardioverter-defibrillator-related adverse events in the Food and Drug Administration Medical Device Reporting System.
    Duggirala HJ; Herz ND; Caños DA; Sullivan RA; Schaaf R; Pinnow E; Marinac-Dabic D
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):87-93. PubMed ID: 22095760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient Alert to detect ICD lead failure: efficacy, limitations, and implications for future algorithms.
    Vollmann D; Erdogan A; Himmrich E; Neuzner J; Becker D; Unterberg-Buchwald C; Sperzel J
    Europace; 2006 May; 8(5):371-6. PubMed ID: 16635998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative outcomes of transvenous extraction of sprint fidelis and riata defibrillator leads: a single center experience.
    Richardson TD; Kolek MJ; Goyal SK; Shoemaker MB; Lewis AA; Rottman JN; Whalen SP; Ellis CR
    J Cardiovasc Electrophysiol; 2014 Jan; 25(1):36-42. PubMed ID: 24028661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.
    Girerd N; Nonin E; Pinot J; Morel E; Flys C; Scridon A; Chevalier P
    Arch Cardiovasc Dis; 2011; 104(6-7):388-95. PubMed ID: 21798471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rates and severity of perforation from implantable cardioverter-defibrillator leads: a 4-year study.
    Turakhia M; Prasad M; Olgin J; Badhwar N; Tseng ZH; Lee R; Marcus GM; Lee BK
    J Interv Card Electrophysiol; 2009 Jan; 24(1):47-52. PubMed ID: 18855128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic fluoroscopic and electrical assessment of implantable cardioverter-defibrillator patients implanted with silicone-polyurethane copolymer (Optim™) coated leads.
    Forleo GB; Di Biase L; Panattoni G; Politano A; Magliano G; Santini L; Natale A; Romeo F
    Europace; 2014 Feb; 16(2):265-70. PubMed ID: 24042736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure rate of the Riata lead under advisory: a report from the CHRS Device Committee.
    Parkash R; Exner D; Champagne J; Mangat I; Thibault B; Healey JS; Tung S; Crystal E; Simpson C; Nery PB; Sterns L; Connors S; Cameron D; Verma A; Beardsall M; Wolfe K; Essebag V; Ayala-Paredes F; Sanatani S; Coutu B; Fraser J; Toal S; Philippon F; Tang AS; Yee R; Krahn A
    Heart Rhythm; 2013 May; 10(5):692-5. PubMed ID: 23333722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical outcomes in patients with implantable cardioverter defibrillators and Sprint Fidelis leads.
    Verlato R; Facchin D; Catanzariti D; Molon G; Zanotto G; Morani G; Brieda M; Zanon F; Delise P; Leoni L; Comisso J; Campo C
    Heart; 2013 Jun; 99(11):799-804. PubMed ID: 23434626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms of Lead Failure by Recall Status and Manufacturer: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Schwarzwald SN; Kersten DJ; Shaikh ZA; Needelman BS; Feldman AM; Germano J; Islam S; Cohen TJ
    J Invasive Cardiol; 2018 Apr; 30(4):147-151. PubMed ID: 29610446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.